‘Remarkable’ Weight Loss With Novel Oral Combo in Phase 1
MADRID — Amycretin, a dual pathway, oral weight loss drug, led to up to 13% body weight loss in participants...
MADRID — Amycretin, a dual pathway, oral weight loss drug, led to up to 13% body weight loss in participants...